Epithelial Organic Cation Transporters Ensure pH-Dependent Drug Absorption in the Airway

Most inhaled beta(2)-adrenergic agonist and anticholinergic bronchodilators have low lipid solubility because of their transient or permanent positive net charge at physiologic pH. Airway absorption of these cationic drugs is incompletely understood. We examined carrier-mediated mechanisms of cation...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory cell and molecular biology Vol. 36; no. 1; pp. 53 - 60
Main Authors Horvath, Gabor, Schmid, Nathalie, Fragoso, Miryam A, Schmid, Andreas, Conner, Gregory E, Salathe, Matthias, Wanner, Adam
Format Journal Article
LanguageEnglish
Published United States Am Thoracic Soc 01.01.2007
American Thoracic Society
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Most inhaled beta(2)-adrenergic agonist and anticholinergic bronchodilators have low lipid solubility because of their transient or permanent positive net charge at physiologic pH. Airway absorption of these cationic drugs is incompletely understood. We examined carrier-mediated mechanisms of cationic drug uptake by human airway epithelia. Airway tissues and epithelial cells, obtained from lung donors without preexisting lung disease, were evaluated for organic cation transporter expression by quantitative RT-PCR and immunofluorescence. For in vitro functional studies on primary airway epithelial cells, uptake of the cationic fluorophore 4-[4-(dimethylamino)-styryl]-N-methylpyridinium (ASP+) was characterized. Quantitative RT-PCR analysis demonstrated high mRNA levels for two polyspecific organic cation/carnitine transporters, OCTN1 and OCTN2, in human airway epithelia. Immunofluorescence of human airway sections confirmed OCTN1/2 protein expression, with a predominant localization to the apical portion of epithelial cells. Primary airway epithelial cells showed a carrier-mediated, temperature-sensitive and saturable uptake of ASP(+). Seventy-five to eighty percent of ASP(+) uptake was inhibited by L-carnitine, an OCTN2-carried zwitterion. The uptake was pH dependent, with approximately 3-fold lower rates at acidic (pH 5.7) than at alkaline (pH 8.2) extracellular pH. Albuterol and formoterol inhibited ASP(+) uptake, suggesting that all these molecules are carried by the same transport mechanism. These findings demonstrate the existence and functional role of a pH-dependent organic cation uptake machinery, namely OCTN1 and OCTN2, in human airway epithelia. We suggest that epithelial OCTN1/2 are involved in the delivery of inhaled cationic bronchodilators to the airway tissue.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Originally Published in Press as DOI: 10.1165/rcmb.2006-0230OC on August 17, 2006
Conflict of Interest Statement: G.H. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. N.S. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. M.A.F. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. A.S. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. G.E.C. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. M.S. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. A.W. received $89,000 in 2006 as a research grant from AstraZeneca.
This work was supported in part by an academic research grant from AstraZeneca and NHLBI grants HL-60644 and HL-66125. G.H. is a recipient of the Bolyai Fellowship of the Hungarian Academy of Sciences.
Correspondence and requests for reprints should be addressed to Adam Wanner, M.D., and Gabor Horvath, M.D., Ph.D., Division of Pulmonary and Critical Care Medicine, University of Miami Miler School of Medicine, P.O. Box 016960 (R-47), Miami, FL 33101. E-mail: awanner@miami.edu and ghorvath.mail@gmail.com
ISSN:1044-1549
1535-4989
DOI:10.1165/rcmb.2006-0230OC